Further studies for CCL25 in in vivo approaches should be performed to prove the capability of CCL25 to recruit cells from healthy AF tissue to damaged tissue areas and further to induce these cells to matrix formation after recruitment. The gene discussed is CCL25; the disease is atrial fibrillation.